Skip to main content

THERMO FISHER SCIENTIFIC INC.

corporate_fare Company Profile

THERMO FISHER SCIENTIFIC INC.

TMO·NYSE·Industrial Applications And Services·CIK 0000097745

Thermo Fisher Scientific Inc. is the world leader in serving science, aiming to enable customers to make the world healthier, cleaner, and safer. The company serves customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, government agencies, and environmental, industrial, research and development, quality, and process control settings. Thermo Fisher delivers innovative technologies, purchasing convenience, and pharmaceutical services through brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. The company expands its capabilities through organic investments in research and development, capacity, and acquisitions. Thermo Fisher reports its business in four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment provides reagents, instruments, and consumables for biological and medical research, drug and vaccine discovery and production, and disease diagnosis. These products and services are used by customers in pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. This segment includes three primary businesses: biosciences, genetic sciences, and bioproduction. The biosciences business offers reagents, instruments, and consumables for biological and medical research in areas like molecular biology and protein biology, new drug and vaccine discovery, and disease diagnosis.

THERMO FISHER SCIENTIFIC INC. (NYSE:TMO) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors TMO SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Shareholders Reject Thermo Fisher's Executive Compensation Plan
  • Thermo Fisher Projects 7% Annual Organic Revenue Growth, Low-Teens EPS Growth Long-Term
  • Thermo Fisher Details Executive Pay Changes After Low Say-on-Pay Vote
  • Thermo Fisher Scientific Files Q1 Report, Reveals $1.075B Microbiology Business Divestiture, and Details Recent Acquisitions
  • Thermo Fisher Raises 2026 Revenue and EPS Outlook, Citing Strong Performance

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$44.56B
Net Income
$6.7B
Diluted EPS
$17.74
Op. Cash Flow
$7.82B
Free Cash Flow
$6.29B
Operating Income
$7.75B
Cash & Equivalents
$9.85B
Total Debt
$42.7B
Debt / Equity
0.80×
Net Margin
15.0%
Shares Outstanding
377M sh
Source: 10-K · filed 2026-02-26 · accession 0000097745-26-000018
Browse all tickers starting with T →
$469.34
52-week range · as of 2026-05-26 $385.46 – $643.99
Market cap
$174.42B
Volume
2.4M (1.0× avg)
3-mo avg 2.5M
Live data · 2026-06-14 03:51 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed TMO - Latest Insights

TMO
May 26, 2026, 7:31 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $449.00
Real-time Price: $469.34 info
Change: +$20.34 (+5%) info
Market Cap: $174.417B info
TMO
May 20, 2026, 8:50 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $450.56
Real-time Price: $469.34 info
Change: +$18.78 (+4%) info
Market Cap: $174.417B info
TMO
May 11, 2026, 7:30 AM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $468.50
Real-time Price: $469.34 info
Change: +$0.840 (+0.18%) info
Market Cap: $174.417B info
TMO
May 01, 2026, 11:00 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $472.21
Real-time Price: $469.34 info
Change: -$2.87 (-0.61%) info
Market Cap: $174.417B info
TMO
Apr 23, 2026, 11:43 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $460.80
Real-time Price: $469.34 info
Change: +$8.54 (+2%) info
Market Cap: $174.417B info
TMO
Apr 23, 2026, 6:09 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $501.00
Real-time Price: $469.34 info
Change: -$31.66 (-6%) info
Market Cap: $174.417B info
TMO
Apr 23, 2026, 6:03 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $499.39
Real-time Price: $469.34 info
Change: -$30.05 (-6%) info
Market Cap: $174.417B info
TMO
Apr 07, 2026, 8:14 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $488.25
Real-time Price: $469.34 info
Change: -$18.91 (-4%) info
Market Cap: $174.417B info
TMO
Mar 24, 2026, 8:02 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $478.40
Real-time Price: $469.34 info
Change: -$9.06 (-2%) info
Market Cap: $174.417B info
TMO
Mar 24, 2026, 8:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $478.40
Real-time Price: $469.34 info
Change: -$9.06 (-2%) info
Market Cap: $174.417B info
TMO
Feb 26, 2026, 12:11 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $513.99
Real-time Price: $469.34 info
Change: -$44.65 (-9%) info
Market Cap: $174.417B info
TMO
Feb 09, 2026, 5:25 PM EST
Filing Type: FWP
Importance Score:
7
Price at Filing: $546.76
Real-time Price: $469.34 info
Change: -$77.42 (-14%) info
Market Cap: $174.417B info
TMO
Jan 29, 2026, 6:02 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $614.41
Real-time Price: $469.34 info
Change: -$145.07 (-24%) info
Market Cap: $174.417B info
TMO
Jan 12, 2026, 6:02 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $618.86
Real-time Price: $469.34 info
Change: -$149.52 (-24%) info
Market Cap: $174.417B info